Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
This piece explains Why Stablecoin Liquidity Matters, linking market health to trading efficiency and user experience for investors.
23,700 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Offerpad rolls out two internal AI platforms, SCOUT and HENRY, as the company pursues 1,000 quarterly home transactio...
A top market strategist calls for exiting the Magnificent 7 amid lofty valuations and fading earnings promises, hinti...
The 2025 ATTOM report shows a sharp slowdown in home flipping activity, with profits slipping to pre-crisis levels as...
The AI surge is lifting demand for hands-on workers like technicians, HVAC specialists, and electricians, with six-fi...
Iran carried out the executions of a 19-year-old star wrestler and two others, sparking investor worry about sanction...
Palantir Technologies is at a crossroads as AI-driven data analytics demand tightens. This long-range look maps 2026-...
Zscaler executives argue that AI cannot substitute for 100% reliable inline traffic inspection, even as AI workloads ...
A Ramsey Solutions employee paid off $118,000 in debt in four years by taking on two side jobs and strict budgeting. ...
The median age for first-time buyers climbed to a record 40, with Zillow’s chief executive warning relief from high c...
The market mood says AI spending is peaking. But one company’s long-term orders hint at a different story. This guide...
An anonymous investor continues to buy the VanEck Uranium and Nuclear ETF every month, betting on nuclear power's lon...